Liposomal Amphotericin B for the Treatment of Systemic Fungal Infections in Patients with Cancer: A Preliminary Study
G. Lopez‐Berestein(The University of Texas MD Anderson Cancer Center), G. P. Bodey(The University of Texas MD Anderson Cancer Center), Rohtesh S. Mehta(The University of Texas MD Anderson Cancer Center), James M. Reuben(The University of Texas MD Anderson Cancer Center), R. L. Juliano(Faculdade de Medicina do ABC), Roy L. Hopfer(The University of Texas MD Anderson Cancer Center), E. M. Hersh(The University of Texas MD Anderson Cancer Center), Victor Fainstein, Mario A. Luna(The University of Texas System), M Keating(The University of Texas MD Anderson Cancer Center), K. Mehta(The University of Texas MD Anderson Cancer Center), Michael G. Rosenblum(The University of Texas MD Anderson Cancer Center), M. P. Sullivan(The University of Texas MD Anderson Cancer Center)
Cited by 408
Related Papers
Pivotal Phase III Trial of Two Dose Levels of Denileukin Diftitox for the Treatment of Cutaneous T-Cell Lymphoma
|Journal of Clinical Oncology|2001|610
Pseudomonas bacteremia. Retrospective analysis of 410 episodes
|Archives of Internal Medicine|1985|361
Systemic candidiasis in cancer patients.
|PubMed|1984|272
The clinical use of circulating tumor cells (CTCs) enumeration for staging of metastatic breast cancer (MBC): International expert consensus paper
|Critical Reviews in Oncology/Hematology|2018|268
Recent Experience With Pseudomonas aeruginosa Bacteremia in Patients With Cancer
|Archives of Internal Medicine|2000|238